The Zhitong Finance App learned that Deshai-B (02516) rose more than 22% in early trading to a high of HK$649, setting a new listing high. As of press release, it rose 19.2% to HK$627, with a turnover of HK$29.387 million.
According to the news, Deshi announced that the company has been included by Hang Seng Index Co., Ltd. in 23 constituent stocks of the Hang Seng Index, including the Hang Seng Composite Index and the Hang Seng Biotech Index, which took effect from September 7 and September 14, and the Hang Seng Hong Kong Stock Connect Artificial Intelligence Themed Index, which also took effect on September 14. The inclusion of the Hang Seng Index constituent stocks mentioned above indicates that the Company has met the criteria for inclusion in Hong Kong Stock Connect transactions.
It is worth noting that Deshi is the only company included in the Hang Seng Biotech Index in this index adjustment, marking the market's high recognition of its technical strength and industry position in the AI-enabled medical field. At the same time, as a genuine AI4S (AI for Science) target, which is scarce in Hong Kong stocks, Deshi-B has built a complete system from data to model, model to product, and product to clinical practice. The AI4S industry wave resonates with the huge demand for capital allocation going south, and the current double inclusion in the Hang Seng Index series is expected to significantly increase the liquidity and trading activity of the company's shares, and there is huge room for improvement in the company's valuation.